Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

OPKO Health Inc. (OPK)

4.55   0.03 (0.66%) 01-17 16:39
Open: 4.62 Pre. Close: 4.52
High: 4.776 Low: 4.54
Volume: 6,313,415 Market Cap: 3,049M
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.786 - 4.806 4.806 - 4.824
Low: 4.493 - 4.514 4.514 - 4.534
Close: 4.517 - 4.549 4.549 - 4.58

Technical analysis

as of: 2021-01-15 4:43:55 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.58     One year: 6.52
Support: Support1: 4.22    Support2: 3.88
Resistance: Resistance1: 4.78    Resistance2: 5.58
Pivot: 4.28
Moving Average: MA(5): 4.47     MA(20): 4.33
MA(100): 3.96     MA(250): 3.20
MACD: MACD(12,26): 0.05     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 73.97     %D(3): 68.72
RSI: RSI(14): 57.25
52-week: High: 6.47  Low: 1.12  Change(%): 188.0
Average Vol(K): 3-Month: 820639  10-Days: 600091

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OPK has closed below upper band by 18.0%. Bollinger Bands are 31.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 14 Jan 2021
OPKO Health's (OPK) BioReference Extends Digital Health Access - Yahoo Finance

Wed, 13 Jan 2021
OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript) - Seeking Alpha

Wed, 13 Jan 2021
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access - Yahoo Finance

Wed, 13 Jan 2021
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q’20 Guidance - Yahoo Finance

Thu, 07 Jan 2021
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know - Nasdaq

Mon, 04 Jan 2021
Should You Buy Opko Health Inc. (OPK) Stock? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 670
Shares Float (M) 382
% Held by Insiders 40.08
% Held by Institutions 30.38
Shares Short (K) 123,660
Shares Short P. Month (K) 130,220

Stock Financials

EPS -0.180
EPS Est This Year -0.190
EPS Est Next Year -0.080
Book Value (p.s.) 2.420
Profit Margin -9.79
Operating Margin -1.96
Return on Assets (ttm) -0.6
Return on Equity (ttm) -7.0
Qtrly Rev. Growth 87.1
Gross Profit (p.s.) 0.395
Sales Per Share 1.746
EBITDA (p.s.) 0.097
Qtrly Earnings Growth
Operating Cash Flow (M) -41
Levered Free Cash Flow (M) -60

Stock Valuations

PE Ratio -25.28
PEG Ratio
Price to Book value 1.88
Price to Sales 2.61
Price to Cash Flow -74.68

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.